Global Contraceptive Devices Patent Landscape Report 2024

Global Contraceptive Devices Market Size

The global contraceptive devices market was valued at USD 24.45 billion in 2023. It is expected to grow at a CAGR of 6.4% during the forecast period of 2024-2032 and attain a market value of USD 42.01 billion by 2032.

The market growth is driven by the rising incidence of sexually transmitted diseases (STDs). The growing technological advancements such as modern contraceptive devices are highly efficient. Patents are focused on advanced technologies such as hormonal contraceptives and barrier contraceptives.

Patent Landscape Report Coverage

The Global Contraceptive Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for contraceptive devices includes a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with contraceptive devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within contraceptive device technologies.

Key Inclusions

• Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for contraceptive device technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with contraceptive devices.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for contraceptive devices and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for contraceptive devices and their relative value in the IP are covered in the final report.

Contraceptive Devices Patent Outlook

• The demand for contraceptive devices is increased by rising sexual health and family planning awareness, which is frequently fueled by public health campaigns and education. People are more likely to look for these products as they become more aware of its advantages and the available options.

• Growth in the contraceptive market is fueled by technological advancements that create more convenient, effective, and user-friendly devices. For example, improvements in male contraceptives, hormonal implants, and IUDs may draw in customers searching for better solutions. Such product developments are expected to impact the patent landscape significantly.

• The availability and use of contraceptive devices are facilitated by improved access to healthcare services, such as family planning clinics and reproductive health services. Policies that promote reproductive health and increased healthcare infrastructure are major factors driving up market demand in many areas.

What are Contraceptive Devices?

Contraceptive devices are medical devices that work by preventing sperm from fertilizing an egg or by changing the reproductive process to prevent pregnancy. These comprise solutions with differing degrees of efficacy and convenience, such as barrier techniques, implants, and intrauterine devices (IUDs).

The components of contraceptive devices include male contraceptive devices and female contraceptive devices. Contraceptive devices can work in different ways, including hormonal contraceptive technology which uses synthetic hormones to control or suppress ovulation and avert pregnancy. More convenient and effective formulations and delivery systems, like pills, patches, injections, and implants, are examples of innovations.

Contraceptive Devices Industry Growth Drivers

Technological Advancement is Expected to Boost the Patent Industry Growth

The efficacy, convenience, and user experience of contraceptive devices are all enhanced by technological advancements. By drawing customers looking for cutting-edge solutions, design and delivery system innovations such as long-lasting and more dependable hormonal implants or non-hormonal alternatives are propelling market expansion. For instance, Kyleena, an intrauterine device (IUD) from Bayer HealthCare, has an extended-release feature and a lower hormone dose. This innovation seeks to offer a more convenient and effective long-term contraceptive option.

There is an increase in patent activity which focuses on enhancing the performance of contraceptive devices. There were around 1,073 patent applications filed in 2022 and by 2023, it increased to 1,195 patents.

Increased Awareness and Education is Expected to Propel Contraceptive Devices Patent Industry

The demand for contraceptive devices rises as reproductive health is becoming more widely known and understood. Public health campaigns and educational programs educate people about the advantages and available options, encouraging responsible family planning. Hence, propelling the market growth.

Contraceptive Devices Patent Segmentation

The report will cover the following sections in detail:

Analysis by Product

• Male Contraceptive Devices
  • Condoms
  • Spermicides

• Female Contraceptive Device
  • Female Condoms
  • Contraceptive Sponges
  • Contraceptive Vaginal Rings
  • Intrauterine Devices
  • Sub-dermal Contraceptive Implants
  • Non-Surgical Permanent Contraceptive Devices

Analysis by Technology

• Hormonal Contraceptives

• Barrier Contraceptives

Contraceptive Devices Patent Segmentation Analysis

The breakup based on product includes male contraceptive devices and female contraceptive devices. Male contraceptive devices work by keeping sperm from attaching themselves to the egg and preventing pregnancy. Condoms and more recent techniques like vasectomy are the available options. Research is still being done on hormonal and non-hormonal alternatives for greater efficacy and convenience.

Detailed technological data will be provided for all specified segments classified in this report.

Contraceptive Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for contraceptive device patents, having around 20,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with contraceptive devices patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the Contraceptive Devices field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Bristol Myers Squibb Co

It was founded in 1887 and has its headquarters located in New York City. Bristol Myers Squibb Co. is a multinational biopharmaceutical company that specializes in cutting-edge treatments for serious illnesses. Its primary activities are research, development, and commercialization of therapeutic solutions.

Conceptus Inc.

Headquartered in Mountain View, California, Conceptus Inc. was established in 1990 and focuses on providing cutting-edge contraceptive options. The business is well-known for creating the hormonal-free, non-surgical Essure permanent birth control system. In order to provide efficient family planning options, Conceptus is focused on developing reproductive health technologies.

Other companies include Alza Corp, Robins Co Inc a H, Contramed Llc, Sebela Vlc Ltd, Human Genome Sciences INC, California University, Ruben Steven M, Texas University, Rosen Craig A, Massachusetts Inst Technology, Pfizer Inc., Janssen Pharmaceutica NV, Dana Farber Cancer Inst INC, Regeneron Pharma, Genentech INC, among others.

Reasons to Purchase this Report

The Contraceptive Devices patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of Contraceptive Devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in Contraceptive Devices.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within contraceptive devices patent landscape.

• Risk Assessment: In technology-intensive fields such as Contraceptive Devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Contraceptive Devices Patent Landscape Report 

• Who are the key players in the contraceptive device patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in contraceptive device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the contraceptive devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in contraceptive devices?
• What are the challenges and opportunities in the contraceptive device patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in contraceptive devices?

Related Reports

Hormonal Contraceptive Market

Contraceptive Drugs Market

Contraceptive Pills Market